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A carbapenem-nonsusceptible Enterobacter aerogenes strain named 3-SP was isolated
from a human case of pneumonia in a Chinese teaching hospital. NDM-1 carbapenemase
is produced by a pNDM-BJ01-like conjugative plasmid designated p3SP-NDM
to account for carbapenem resistance of 3-SP. p3SP-NDM was fully sequenced
and compared with all publically available pNDM-BJ01-like plasmids. The genetic
differences between p3SP-NDM and pNDM-BJ01 include only 18 single nucleotide
polymorphisms, a 1 bp deletion and a 706bp deletion. p3SP-NDM and pNDM-BJ01
harbor an identical Tn125 element organized as ISAba125, blaNDM−1, bleMBL, 1trpF,
dsbC, cutA, 1groES, groEL, ISCR27, and ISAba125. The blaNDM−1 surrounding
regions in these pNDM-BJ01-like plasmids have a conserved linear organization
ISAba14-aphA6-Tn125-unknown IS, with considerable genetic differences identified
within or immediately downstream of Tn125. All reported pNDM-BJ01-like plasmids are
exclusively found in Acinetobacter, whereas this is the first report of identification of a
pNDM-BJ01-like plasmid in Enterobacteriaceae.
Keywords: Enterobacter aerogenes, NDM-1, Plasmid, p3SP-NDM
Enterobacter aerogenes is a Gram-negative bacterium widely found in the human gastrointesti-
nal tract and in the environment, and generally non-pathogenic to healthy humans. Since 1990s,
E. aerogenes has become an important opportunistic pathogen commonly affecting those with
weakened immune systems to cause hospital-acquired infections such as pneumonia, bacteremia,
urinary tract infection, surgical site infection, and meningitis (Georghiou et al., 1995; Davin-Regli
et al., 1996; De Gheldre et al., 1997; Jalaluddin et al., 1998; Ronveaux et al., 1999).
E. aerogenes strains isolated from hospitalized patients generally exhibit high resistance to com-
monly used broad-spectrum antibiotics; in particular, the use of carbapenems imipenem and
meropenem as the first-line antimicrobial agents for treating serious or refractory infections has
led to considerable increase in prevalence of carbapenem-resistant E. aerogenes (De Gheldre et al.,
1997; Chen et al., 2008; Lavigne et al., 2013). Carbapenem resistance of E. aerogenes is usu-
ally a result of production of plasmid-encoding carbapenemases such as KPC (Chen et al., 2014;
Kuai et al., 2014; Luo et al., 2014; Qin et al., 2014), IMP (Biendo et al., 2008; Ding et al., 2014),
VIM (Biendo et al., 2008; Souli et al., 2008) and NDM (Ho et al., 2012), decreased membrane
permeability (due to altered porin expression or eﬄux pump overexpression) together with
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production of AmpC-type cephalosporinase or extended-
spectrum β-lactamase (ESBL) (Bornet et al., 2003; Lavigne et al.,
2012, 2013), and lipopolysaccharide modification (Leying et al.,
1991).
The 47.27Kb plasmid pNDM-BJ01 is isolated from a clinical
A. lwoffii strain in China in 2010 (Hu et al., 2012) and it cannot
be assigned into any known incompatibility group. In this study,
phenotypic and biochemical experiments combined with plasmid
sequencing and comparative genomics analyses disclose that pro-
duction of NDM-1 by a pNDM-BJ01-like conjugative plasmid
p3SP-NDM accounts for carbapenem resistance of a clinical E.
aerogenes isolate recovered from a human case of pneumonia in
a Chinese teaching hospital.
Materials and Methods
Bacterial Strains and Identification
The use of human specimens and all related experimental pro-
tocols were approved by the Committee on Human Research
of indicated institutions and carried out in accordance with
the approved guidelines, and moreover the informed con-
sent was obtained from indicated patient. All the bacterial
strains in this study were subjective for species identification by
BioMérieux VITEK 2, Bruker MALDI Biotyper, and 16s rRNA
gene sequencing. For determination of 16S rRNA gene sequence,
the almost complete coding region of 16S rRNA gene was ampli-
fied by PCR with the universal primers 27f (AGAGTTTGATC-
CTGGCTCAG) and 1492r (TACCTTGTTACGACTT) (Frank
et al., 2008). The major carbapenemase and ESBL genes as listed
in Table S1 were subjected to PCR detection. All PCR amplicons
were sequenced on ABI 3730 Sequencer with the same primers
for PCR.
Plasmid Transfer
Plasmid conjugal transfer experiments were carried out with the
rifampin-resistant E. coli EC600 being used as recipient and the
blaNDM-positive strain 3-SP as donor. 3ml of overnight culture
of each of donor and recipient bacteria were mixed together, har-
vested, and resuspended in 80µl of Brain Heart Infusion (BHI)
broth (BD Biosciences). Themixture was spotted on a 1 cm2 filter
membrane that was placed on BHI agar (BD Biosciences) plate,
and then incubated for mating at 37◦C for 12–18 h. Bacteria were
washed from filter membrane and spotted on Muller-Hinton
(MH) agar (BD Biosciences) plate containing 750µg/ml rifampin
and 200µg/ml ampicillin for selection of blaNDM-positive E. coli
transconjugants.
To prepare competent cells for plasmid electroporation,
200ml of overnight culture of E. coli DH10B in Super Optimal
Broth (SOB) at an optical density (OD600) of 0.4–0.6 was washed
three times with electroporation buffer (0.5M mannitol and 10%
glycerol) and concentrated into a final volume of 2ml. 1µg of
plasmid DNA, which was isolated from 3-SP with QIAGEN Plas-
mid Midi Kit, were mixed with 100µl of competent cells for
electroporation at 25µF, 200 , and 2.5 Kv. The resulting cells
were suspended in 500µl of SOB, and an appropriate aliquot was
spotted on SOB agar plate containing 200µg/ml ampicillin for
selection of blaNDM-positive E. coli electroporants.
S1-PFGE and Southern Blot
Bacterial genomic DNA was prepared in agarose plugs and
digested with S1 nuclease (Takara). The linearized plasmids and
partially digested genomic DNA were separated through the
CHEF-Mapper XA PFGE system (Bio-Rad). The DNA frag-
ments were stained with ethidium bromide (EtBr), transferred
to a Hybond N+ membrane (GE Amersham Biosciences) and
hybridized with a DIG-labeled probe specific to blaNDM (Rasheed
et al., 2013). Probe labeling and signal detection were car-
ried out with DIG high primer DNA labeling and detection
starter kit II according to the manufacturer’s instructions (Roche
Diagnostics).
Detection of Carbapenemase Activity
Activity of class A/B/D carbapenemases was determined by Car-
baNP test (Dortet et al., 2012) with modifications. Overnight bac-
terial cell culture inMH broth was diluted 1:100 into 3ml of fresh
MH broth, and bacteria were allowed to grow at 37◦C with shak-
ing at 200 rpm to reach an OD600 of 1.0–1.4. If required, ampi-
cillin was used at 200µg/ml. Bacterial cells were harvested from
2ml of the above culture, and washed twice with 20mMTris-HCl
(pH 7.8). Cell pellets were resuspended in 500µl of 20mM Tris-
HCl (pH 7.8), and lysed by soniation, followed by centrifugation
at 10,000×g at 4 ◦C for 5min. 50µl of the supernatant (the enzy-
matic bacterial suspension) were mixed with 50µl of substrate I
to V, respectively, followed by incubation at 37◦C for a maximum
of 2 h. Substrate I: 0.054% phenol red plus 0.1mM ZnSO4 (pH
7.8). Substrate II: 0.054% phenol red plus 0.1mM ZnSO4 (pH
7.8), and 0.6 mg/µl imipenem. Substrate III: 0.054% phenol red
plus 0.1mM ZnSO4 (pH 7.8), 0.6 mg/µl mg imipenem, and 0.8
mg/µl tazobactam. Substrate IV: 0.054% phenol red plus 0.1mM
ZnSO4 (pH 7.8), 0.6 mg/µl mg imipenem, and 3mM EDTA (pH
7.8). Substrate V: 0.054% phenol red plus 0.1mM ZnSO4 (pH
7.8), 0.6 mg/µl mg imipenem, 0.8 mg/µl tazobactam, and 3mM
EDTA (pH 7.8).
Determination of Minimum Inhibitory
Concentration (MIC)
TheMIC values of indicated bacterial strains were tested by using
VITEK 2 according to manufacturer’s instructions, and antimi-
crobial susceptibility was judged by Clinical and Laboratory
Standards Institute (CLSI) standard.
Determination of Plasmid DNA Sequence
The chromosome DNA-free plasmid DNA was isolated from
the cell cultures of indicated E. coli transconjugant using a Qia-
gen large construct kit, and then sequenced by using whole-
genome shotgun strategy in combination with Illumina HiSeq
2500 sequencing technology. The contigs were assembled with
Velvet, and the gaps were filled through combinatorial PCR
and Sanger Sequencing on ABI 3730 Sequencer. The genes were
predicted with GeneMarkS and further annotated by BLASTP
against UniPort and NR databases.
Nucleotide Sequence Accession Numbers
The complete sequence of plasmid p3SP-NDM was submitted to
GenBank under accession number KP900015.
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Results
Carbapenem-nonsusceptible E. aerogenes 3-SP
In June 2012, an 86-year-old male with cough and fever vis-
ited a teaching hospital in Xi’an city of China. The patient had
underlying sequelae of cerebral hemorrhage, and complained of
recurrent pulmonary infection. The patient received oral admin-
istration with cefradine for a week, but his symptoms did not
improve. The patient was subsequently hospitalized, and chest
X-ray examination confirmed presence of bilateral pulmonary
infection and he was accordingly diagnosed to have pneumonia.
The sputum specimens were sampled on the same day of admis-
sion. On the next day, round bacterial colonies were observed
after cultivation of sputum on MH agar, and the bacterial iso-
late designated 3-SP was identified as E. aerogenes by VITEK
2, Bruker MALDI Biotyper, and 16s rRNA gene sequencing.
The antimicrobial susceptibility test using VITEK 2 indicated
3-SP was resistant to multiple β-lactam antibiotics including
imipenem and meropenem but remained susceptible to fluoro-
quinolones. The patient accordingly received intravenous admin-
istration with levofloxacin, and his symptoms associated with
pulmonary infection disappeared and he was discharged after 10
days of antimicrobial treatment.
NDM-producing Plasmid p3SP-NDM
PCR detection of the major ESBL and carbapenemase genes
(Table S1) indicated presence of only blaNDM in E. aerogenes
3-SP (Figure S1), which was confirmed by PCR amplicon
sequencing. A blaNDM-positive E. coli EC600 transconjugant
named 3-SP-NDM-EC600 and a blaNDM-positive E. coli
DH10B electroporant designated 3-SP-NDM-DH10B were
obtained. The S1-PFGE/southern hybridization assay detected
a ∼48 kb plasmid in each of 3-SP, 3-SP-NDM-EC600 and
3-SP-NDM-DH10B, which could hybridize with a blaNDM-
specific probe (Figure S2). The modified CarbaNP test showed
that 3-SP, 3-SP-NDM-EC600, and 3-SP-NDM-DH10B had
Ambler class B carbapenemase activity (Figure S3). The
antibiotic susceptibility test showed that 3-SP, 3-SP-NDM-
EC600, and 3-SP-NDM-DH10B were highly resistant to all
the penicillin, β-lactamase, monobactam, cephalosporin, and
carbapenem drugs tested, but remained to be susceptible to
fluoroquinolones, furanes, aminoglycosides, and sulfanilamide
tested (Table 1). The above results indicated that 3-SP con-
tained a conjugative NDM-encoding plasmid (designated
p3SP-NDM), which accounted for carbapenem resistance of
3-SP and could be transferred into and mobilized in E. coli
recipients.
TABLE 1 | MIC values and antimicrobial susceptibility.
Category Antibiotics MIC (µg/ml)/antimicrobial susceptibility
3-SP 3-SP-NDM-EC600 3-SP-NDM-DH10B EC600 DH10B
Penicillin Ampicillin >=32/R >=32/R >=32/R 16/I <=2/S
Ampicillin/sulbactam >=32/R >=32/R >=32/R 8/S <=2/S
Piperacillin >=128/R >=128/R >=128/R <=4/S <=4/S
Piperacillin/tazobactam >=128/R 64/R 64/R <=4/S <=4/S
Monobactam Aztreonam >=64/R >=64/R >=64/R <=1/S <=1/S
Cephalosporin Cefazolin >=64/R >=64/R >=64/R <=4/S <=4/S
Cefuroxime sodium >=64/R >=64/R >=64/R 16/I 4/S
Cefuroxime axetil >=64/R >=64/R >=64/R 16/I 4/S
Cefotetan >=64/R >=64/R 32/R <=4/S <=4/S
Ceftriaxone >=64/R >=64/R >=64/R <=1/S <=1/S
Ceftazidime >=64/R >=64/R >=64/R <=1/S <=1/S
Carbapenem Imipenem 8/R >=16/R >=16/R <=1/S <=1/S
Meropenem 8/R 4/R 8/R <=0.25/S <=0.25/S
Fluoroquinolone Ciprofloxacin 2/I <=0.25/S <=0.25/S <=0.25/S <=0.25/S
Levofloxacin 2/S 0.5/S <=0.25/S 1/S <=0.25/S
Furane Macrodantin 64/I <=16/S <=16/S <=16/S <=16/S
Aminoglycoside Amikacin <=2/S <=2/S <=2/S <=2/S <=2/S
Gentamicin <=1/S <=1/S <=1/S <=1/S <=1/S
Tobramycin <=1/S <=1/S <=1/S <=1/S <=1/S
Sulfanilamide Trimethoprim/sulfamethoxazole <=20/S <=20/S <=20/S <=20/S <=20/S
S, sensitive; R, resistant; I, Intermediate.
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Plasmid DNA was isolated from 3-SP-NDM-EC600, and the
whole genome sequence of p3SP-NDMwas determined to 46,570
bp in length with a 137 fold coverage, forming a circular DNA
sequence with a total of 45 open reading frames annotated
(Figure 1).
Comparative Genomics of pNDM-BJ01-like
Plasmids
p3SP-NDM is highly similar to pNDM-BJ01 with genetic differ-
ences including only 18 single nucleotide polymorphisms and an
1 bp deletion (Table S2) and a 706 bp deletion (Figure S3, see also
below).
Linear structural comparison (Figure 2) was performed with
whole genome sequences of p3SP-NDM, pNDM-BJ01 and all the
six additional pNDM-BJ01-like plasmids pNDM-BJ02 (Hu et al.,
2012), pNDM-40-1 (Jones et al., 2014), pNDM-AB (Zhang et al.,
2013), pNDM-Iz4b (KJ547696), pAbNDM-1 (JN377410), and
pM131_NDM1 (JX072963) (collected fromGenBank onNovem-
ber 20, 2014). p3SP-NDM and pNDM-Iz4b essentially had the
same genomic organization.
The above eight plasmids contain a highly conserved back-
bone composed of two separate regions of plasmid replica-
tion/transfer and one region of type VI section system, with only
one structural polymorphism that a 706 bp fragment (nucleotide
position 43,861–44,566 in pNDM-BJ01; located within the plas-
mid replication/transfer region and contains only one annotated
gene encoding hypothetical protein) is deleted from p3SP-NDM
and pNDM-Iz4b relative to all the other plasmids (Figure 2).
FIGURE 1 | Schematic map of p3SP-NDM. Genes are denoted by arrows
and colored based on gene function classification. The innermost circle
presents GC-Skew [(G − C)/(G + C)] with a window size of 500 bp and a
step size of 20 bp. The blue circle presents GC content. Shown also are
backbone and accessory module regions. All the gene organization figures in
this work were drawn by using the Inkscape software (https://inkscape.org/).
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FIGURE 2 | Linear comparison of sequenced plasmids. Genes are denoted by arrows and colored based on gene function classification. Dark green shading
regions denote regions of homology (>99% nucleotide similarity).
As for accessory modules (Figure 2), each of these eight plas-
mids contains a blaNDM−1 gene cluster located around nucleotide
position 5685; in addition, pNDM-AB harbors an additional
3.5 Kb accessory region, which is located around nucleotide
position 5570 and composed of an ISAba14 element and a
gene encoding type I restriction-modification system methyl
transferase subunit.
The blaNDM−1 gene clusters from the above eight plasmids
show a conserved linear organization ISAba14-aphA6-Tn125-
unknown IS, and the ISAba14-aphA6 and unknown IS frag-
ments are essentially identical structurally in these plasmids while
structural differences occur within or immediately downstream
of the composite transposon Tn125 (Figure 3). pNDM-BJ01
and p3SP-NDM contain the prototype Tn125, which is sequen-
tially organized as ISAba125, blaNDM−1, bleMBL (bleomycin resis-
tance),1trpF, dsbC, cutA,1groES, groEL, ISCR27, and ISAba125
(Figure 3); Tn125 is inserted into a site downstream of aphA6
(aminoglycoside resistance), which is evidenced by presence of
GTT direct repeats at both ends, and the two copies of ISAba125
likely target blaNDM−1 surrounding sequences to promote forma-
tion and transposition of Tn125 (Poirel et al., 2012).
Compared to the counterpart in pNDM-BJ01/p3SP-NDM,
Tn125 in pNDM-40-1 (Figure 3) is a truncated version with
two deletions: a 1298 bp deletion within original bleMBL-1trpF-
dsbC to generate 1bleMBL-1dsbC, and a 150 bp deletion within
ISCR27 (Jones et al., 2014). A third copy of ISAba125 or an
intact ISAba11 element is inserted immediately downstream of
the intact Tn125 of pAbNDM-1 or pM131_NDM1, respectively,
while the downstream copy of ISAba125 is deleted from Tn125
of pNDM-BJ02 (Figure 3). As for Tn125 in pNDM-AB, cutA-
1groES-groEL-ISCR27 observed in pNDM-BJ01 is replaced by
1cutA-mph(E)- msr(E), leading to absence of downstream GTT
direct repeat (Zhang et al., 2013); by contrast, GTT direct repeats
are intact in all other seven plasmids (Figure 3). Themph(E) and
msr(E) genes confer macrolide/triamilide resistance (Michael
et al., 2012).
Discussion
NDM, initially identified in Klebsiella pneumoniae in 2009, is
a metallo-β-lactamase (MBL) capable of hydrolyzing almost all
clinically used β-lactams (Tiwari and Moganty, 2013), and the
blaNDM genes have been found in a large collection of Gram-
negative bacteria of clinical, environmental and animal origins,
especially including Acinetobacter, Enterobacteriaceae, and Pseu-
domonas (Nordmann et al., 2011; Johnson and Woodford, 2013;
Dortet et al., 2014). Fourteen NDM variants have been described,
differing by several amino acid changes, and a few of them
have been tested for their enzymatic kinetics, which denotes
that amino acid substitution is a major source of MBL activity
extension (Nordmann et al., 2012; Tada et al., 2013). Neverthe-
less, a systematic characterization of enzymatic kinetics of all the
identified NDM variants is needed.
Intact ISAba125 has never been found in bacterial species
other than Acinetobacter, and thus ISAba125 ought to originate
from Acinetobacter. blaNDM−1 is most likely generated in an
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FIGURE 3 | Linear comparison of blaNDM−1 gene clusters. Genes are denoted by arrows and colored. Dark green shading regions denote regions of homology
(>99% nucleotide similarity).
Acinetobacter background by a fusion event between aphA6 and
an ancestral metallo-β-lactamase gene (Poirel et al., 2012; Tole-
man et al., 2012; Zong and Zhang, 2013). Insertion of various
derivates of blaNDM−1-carrying Tn125 have been found within
Acinetobacter chromosomes (Pfeifer et al., 2011; Bonnin et al.,
2012; Partridge and Iredell, 2012; Poirel et al., 2012) and plas-
mids (Hu et al., 2012; Partridge and Iredell, 2012; Zhang et al.,
2013; Zong and Zhang, 2013; Jones et al., 2014) at different
locations, and moreover Tn125 derivates also represent plasmid-
borne blaNDM−1 contexts in Enterobacteriaceae (Sekizuka et al.,
2011; Mcgann et al., 2012; Partridge and Iredell, 2012; Fiett
et al., 2014; Mataseje et al., 2014). These indicate emergency of
blaNDM−1in Acinetobacter and then dissemination among Enter-
obacteriaceae. In addition, the upstream copy of ISAba125, either
intact or interrupted by othermobile elements, of Tn125 provides
blaNDM with a strong promoter to drive high-level production of
NDM enzymes (Poirel et al., 2011; Toleman et al., 2012).
At the time of writing this paper, there are at least eight
additional pNDM-BJ01-like plasmids have been deposited in
GenBank. All the above plasmids are exclusively found in Acine-
tobacter species including A. lwoffii, A. baumannii, A. ereziniae,
A. pittii, and an unidentified Acinetobacter species from China,
India, and Pakistan. This is the first report of identification
of a pNDM-BJ01-like plasmid in Enterobacteriaceae, indicat-
ing spread of pNDM-BJ01-like plasmids from Acinetobacter to
Enterobacteriaceae.
There is only one preliminary report describing detection
of blaNDM in E. aerogenes, and this strain harbors a ∼50Kb
blaNDM−1-encoding plasmid and is recovered from the stool
sample of a 1-year-old infant with cough and intermittent fever
in Hunan Province of China (Ho et al., 2012). This work presents
extended evidence that NDM-1 is produced by a conjugative
46.57Kb plasmid p3SP-NDM, and accounts for carbapenem
resistance of clinical E. aerogenes; phenotypic and biochemical
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experiments combined with plasmid sequencing and compara-
tive genomics analyses give a deeper understanding of antibiotic
resistance mechanism of this NDM-1-producing E. aerogenes
strain.
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Figure S1 | PCR detection of bla genes. The major ESBL and carbapenemase
genes (Table S1) were screened by PCR with strains 3-SP, 3-SP-NDM-EC600,
3-SP-NDM-DH10B, ATCC BAA-2146 (a NDM-1-producing reference strain of
K. pneumoniae, Rasheed et al., 2013), EC600, and DH10B. Of all the bla genes
detected, only blaNDM was shown to be present in each of 3-SP,
3-SP-NDM-EC600, and 3-SP-NDM-DH10B.
Figure S2 | S1-PFGE/Southern blot. The S1-digested genomic DNA samples
was analyzed on an EtBr-stained PFGE gel (A), and then subjected to Southern
blot hybridization with a DIG-labeled probe specific to blaNDM−1(B).
Figure S3 | Detection of carbapenemase activity. In the presence of any
carbapenemase, relevant carbapenems are hydrolyzed and transformed into its
carboxylic form, thus leading to a pH decrease which is detected by a color
change of phenol red solution (red to yellow–orange). Ambler class A
carbapenemases are, at least partially, inhibited by tazobactam, whereas class B
carbapenemases (metallo-ß-lactamases) are inhibited by divalent cation chelators
such as EDTA. There is no available chemical inhibitor for class D
carbapenemases. In this study, the blaNDM-psitive strains 3-SP,
3-SP-NDM-EC600, 3-SP-NDM-DH10B, and ATCC BAA-2146 had class B
carbapenemase activity. As expected, E. coli EC600 and DH10B had no
carbapenemase activity.
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